FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170839475> ?p ?o ?g. }

• W2170839475 abstract "Elderly patients with metastatic melanoma have different disease characteristics and a poorer prognosis than younger patients. Data from clinical trials and expanded access programmes (EAPs) suggest ipilimumab confers a consistent survival benefit and has a similar safety profile across different age groups of patients with metastatic melanoma. Here we report the efficacy and safety of ipilimumab 3 mg/kg in elderly patients enrolled in an EAP in Italy.Patients aged > 70 years with pretreated melanoma received ipilimumab 3 mg/kg every 3 weeks for four doses through an EAP. Tumour response was evaluated at baseline and after completion of induction therapy using immune-related response criteria and patients were monitored throughout the treatment period for adverse events (AEs), including immune-related AEs.The immune-related disease control rate among 188 evaluable patients was 38%, including four patients with an immune-related complete response, 24 with an immune-related partial response and 44 with immune-related stable disease. Median progression-free survival (PFS) was 4.0 months and the 1- and 2-year PFS rates were 21% and 12%, respectively. Median overall survival (OS) was 8.9 months; 1- and 2-year OS rates were 38% and 22%, respectively. The safety profile of ipilimumab was consistent with that observed in the general population of the Italian EAP and treatment-related AEs generally resolved within a median of 2 weeks with treatment as per protocol-specific guidelines.These results suggest ipilimumab is a feasible treatment option in elderly patients with metastatic melanoma. Ipilimumab treatment was generally well tolerated and resulted in clinical benefit and extended survival in elderly patients treated at centres in Italy." @default.
• W2170839475 created "2016-06-24" @default.
• W2170839475 creator A5018536695 @default.
• W2170839475 creator A5021447572 @default.
• W2170839475 creator A5029398339 @default.
• W2170839475 creator A5030046392 @default.
• W2170839475 creator A5030289522 @default.
• W2170839475 creator A5031591368 @default.
• W2170839475 creator A5032506137 @default.
• W2170839475 creator A5036579401 @default.
• W2170839475 creator A5040419545 @default.
• W2170839475 creator A5042764150 @default.
• W2170839475 creator A5042989547 @default.
• W2170839475 creator A5048343406 @default.
• W2170839475 creator A5056702454 @default.
• W2170839475 creator A5057499961 @default.
• W2170839475 creator A5057828080 @default.
• W2170839475 creator A5058700684 @default.
• W2170839475 creator A5060382649 @default.
• W2170839475 creator A5062210857 @default.
• W2170839475 creator A5071929183 @default.
• W2170839475 creator A5085172464 @default.
• W2170839475 date "2014-04-04" @default.
• W2170839475 modified "2023-10-11" @default.
• W2170839475 title "Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme" @default.
• W2170839475 cites W1556990476 @default.
• W2170839475 cites W1973762645 @default.
• W2170839475 cites W1977607846 @default.
• W2170839475 cites W2034478206 @default.
• W2170839475 cites W2039232461 @default.
• W2170839475 cites W2078616035 @default.
• W2170839475 cites W2097995306 @default.
• W2170839475 cites W2099199992 @default.
• W2170839475 cites W2100158834 @default.
• W2170839475 cites W2102031533 @default.
• W2170839475 cites W2103845135 @default.
• W2170839475 cites W2109653150 @default.
• W2170839475 cites W2111877246 @default.
• W2170839475 cites W2118863192 @default.
• W2170839475 cites W2123363005 @default.
• W2170839475 cites W2137723371 @default.
• W2170839475 cites W2142987060 @default.
• W2170839475 cites W2151227750 @default.
• W2170839475 cites W2158734599 @default.
• W2170839475 cites W2167255026 @default.
• W2170839475 cites W2168334855 @default.
• W2170839475 cites W2494190851 @default.
• W2170839475 cites W2597369162 @default.
• W2170839475 cites W2603903176 @default.
• W2170839475 cites W2969153079 @default.
• W2170839475 cites W6288358 @default.
• W2170839475 cites W1982775938 @default.
• W2170839475 doi "https://doi.org/10.1186/1756-9966-33-30" @default.
• W2170839475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3996509" @default.
• W2170839475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24708900" @default.
• W2170839475 hasPublicationYear "2014" @default.
• W2170839475 type Work @default.
• W2170839475 sameAs 2170839475 @default.
• W2170839475 citedByCount "87" @default.
• W2170839475 countsByYear W21708394752014 @default.
• W2170839475 countsByYear W21708394752015 @default.
• W2170839475 countsByYear W21708394752016 @default.
• W2170839475 countsByYear W21708394752017 @default.
• W2170839475 countsByYear W21708394752018 @default.
• W2170839475 countsByYear W21708394752019 @default.
• W2170839475 countsByYear W21708394752020 @default.
• W2170839475 countsByYear W21708394752021 @default.
• W2170839475 countsByYear W21708394752022 @default.
• W2170839475 crossrefType "journal-article" @default.
• W2170839475 hasAuthorship W2170839475A5018536695 @default.
• W2170839475 hasAuthorship W2170839475A5021447572 @default.
• W2170839475 hasAuthorship W2170839475A5029398339 @default.
• W2170839475 hasAuthorship W2170839475A5030046392 @default.
• W2170839475 hasAuthorship W2170839475A5030289522 @default.
• W2170839475 hasAuthorship W2170839475A5031591368 @default.
• W2170839475 hasAuthorship W2170839475A5032506137 @default.
• W2170839475 hasAuthorship W2170839475A5036579401 @default.
• W2170839475 hasAuthorship W2170839475A5040419545 @default.
• W2170839475 hasAuthorship W2170839475A5042764150 @default.
• W2170839475 hasAuthorship W2170839475A5042989547 @default.
• W2170839475 hasAuthorship W2170839475A5048343406 @default.
• W2170839475 hasAuthorship W2170839475A5056702454 @default.
• W2170839475 hasAuthorship W2170839475A5057499961 @default.
• W2170839475 hasAuthorship W2170839475A5057828080 @default.
• W2170839475 hasAuthorship W2170839475A5058700684 @default.
• W2170839475 hasAuthorship W2170839475A5060382649 @default.
• W2170839475 hasAuthorship W2170839475A5062210857 @default.
• W2170839475 hasAuthorship W2170839475A5071929183 @default.
• W2170839475 hasAuthorship W2170839475A5085172464 @default.
• W2170839475 hasBestOaLocation W21708394751 @default.
• W2170839475 hasConcept C121608353 @default.
• W2170839475 hasConcept C126322002 @default.
• W2170839475 hasConcept C143998085 @default.
• W2170839475 hasConcept C197934379 @default.
• W2170839475 hasConcept C203014093 @default.
• W2170839475 hasConcept C2775832928 @default.
• W2170839475 hasConcept C2777658100 @default.
• W2170839475 hasConcept C2777701055 @default.
• W2170839475 hasConcept C2781433595 @default.
• W2170839475 hasConcept C2908647359 @default.

• next